Hyperspectral imaging as a part of pharmaceutical product design
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Standard
Hyperspectral imaging as a part of pharmaceutical product design. / Bøtker, Johan; Wu, Jian X.; Rantanen, Jukka.
Data Handling in Science and Technology. Elsevier, 2020. p. 567-581 (Data Handling in Science and Technology, Vol. 32).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - Hyperspectral imaging as a part of pharmaceutical product design
AU - Bøtker, Johan
AU - Wu, Jian X.
AU - Rantanen, Jukka
PY - 2020
Y1 - 2020
N2 - Imaging is getting an important element of the modern drug development process. Different hyperspectral imaging tools can provide in-depth understanding of complex pharmaceutical products including not only phenomena captured by the laboratory-based off-line instruments but also increasingly tools capable of fulfilling the process analytical measurement scenarios. Information related to spatial distribution of the components in pharmaceutical products can be explored using infrared, near-infrared, Raman, and ultraviolet mapping, as well as using RGB imaging. These tools are generally accepted by the regulatory bodies, and at the same time, they are becoming a natural part of drug development process. In the future, hyperspectral imaging will be a key enabling part of the continuously operating production systems.
AB - Imaging is getting an important element of the modern drug development process. Different hyperspectral imaging tools can provide in-depth understanding of complex pharmaceutical products including not only phenomena captured by the laboratory-based off-line instruments but also increasingly tools capable of fulfilling the process analytical measurement scenarios. Information related to spatial distribution of the components in pharmaceutical products can be explored using infrared, near-infrared, Raman, and ultraviolet mapping, as well as using RGB imaging. These tools are generally accepted by the regulatory bodies, and at the same time, they are becoming a natural part of drug development process. In the future, hyperspectral imaging will be a key enabling part of the continuously operating production systems.
KW - Chemical imaging
KW - Near-IR (NIR) imaging
KW - Pharmaceutical
KW - Raman imaging
KW - Tablets
U2 - 10.1016/B978-0-444-63977-6.00022-5
DO - 10.1016/B978-0-444-63977-6.00022-5
M3 - Book chapter
AN - SCOPUS:85072674681
T3 - Data Handling in Science and Technology
SP - 567
EP - 581
BT - Data Handling in Science and Technology
PB - Elsevier
ER -
ID: 245615615